Search Results for: press release

Vatican in turmoil as it kills its upcoming stem cell conference

The Vatican has reportedly killed its planned upcoming stem cell conference. What’s the scoop? Last year the Vatican had an invitation only stem cell conference at which embryonic stem cell researchers, who are presumably going to Hell, and discussion of embryonic stem cell research were banned. I did a number of posts on this 2011 […]

Vatican in turmoil as it kills its upcoming stem cell conference Read More »

Bad news as Geron to quit hESC SCI trial for financial reasons

Geron-300x2212

Reportedly, Geron has decided to only focus on cancer research and for financial reasons has shut down its hESC trial for spinal cord injury. This is a very sad day for stem cell science. (Update in 2020: the firm still exists, but is working in different areas. The stock has struggled.) No more spinal cord

Bad news as Geron to quit hESC SCI trial for financial reasons Read More »

Stem cells gone wild? What really happens after a transplant

Geron-300x2212

What really happens to cells after they a stem cell transplant into a patient? Once these cells, which have spent weeks in a lab environment, are injected into a person, what happens next? This is arguably the most important question in the regenerative medicine field, but there are few answers. We are literally mostly in

Stem cells gone wild? What really happens after a transplant Read More »

“Alternative” to IPS cells, ICSP, are very cool, but for now a no-go for the FDA

A group of researchers led by Evan Snyder (paper discussed here) published a paper in PNAS on a new type of neural stem-like cell whose pluripotency can be turned ON or OFF by turning the v-myc gene ON or OFF using a conditional system of expression, called a “Tet-ON” system. In this system, tetracycline or its

“Alternative” to IPS cells, ICSP, are very cool, but for now a no-go for the FDA Read More »

CIRM Appoints Ellen Feigal, UC Davis Grad and Executive Med Director of Amgen as VP

CIRM announced today that it had appointed Ellen Feigal, M.D., to be its first VP for Research Development. Dr. Feigal will begin the job on Jan. 31. Dr. Feigal is a graduate of UC Davis Med School (where I am writing this from; go UC Davis SOM!) and is currently Executive Medical Director for Global

CIRM Appoints Ellen Feigal, UC Davis Grad and Executive Med Director of Amgen as VP Read More »